Working… Menu

Prevention in Recipients With Primary IgA Nephropathy of Recurrence After Kidney Transplantation: ATG-F Versus Basiliximab as Induction Immunosuppressive Treatment (PIRAT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02523768
Recruitment Status : Terminated (Difficulties for recruting patients)
First Posted : August 14, 2015
Last Update Posted : January 20, 2021
Information provided by (Responsible Party):
Centre Hospitalier Universitaire de Saint Etienne

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : January 24, 2020
Actual Study Completion Date : February 24, 2020